Classical and atypical agonists activate M1 muscarinic acetylcholine receptors through common mechanisms

Alena Randáková, Eva Dolejší, Vladimír Rudajev, Pavel Zimčík, Vladimír Doležal, Esam E. El-Fakahany, Jan Jakubík

Research output: Contribution to journalArticlepeer-review

4 Scopus citations


We mutated key amino acids of the human variant of the M1 muscarinic receptor that target ligand binding, receptor activation, and receptor-G protein interaction. We compared the effects of these mutations on the action of two atypical M1 functionally preferring agonists (N-desmethylclozapine and xanomeline) and two classical non-selective orthosteric agonists (carbachol and oxotremorine). Mutations of D105 in the orthosteric binding site and mutation of D99 located out of the orthosteric binding site decreased affinity of all tested agonists that was translated as a decrease in potency in accumulation of inositol phosphates and intracellular calcium mobilization. Mutation of D105 decreased the potency of the atypical agonist xanomeline more than that of the classical agonists carbachol and oxotremorine. Mutation of the residues involved in receptor activation (D71) and coupling to G-proteins (R123) completely abolished the functional responses to both classical and atypical agonists. Our data show that both classical and atypical agonists activate hM1 receptors by the same molecular switch that involves D71 in the second transmembrane helix. The principal difference among the studied agonists is rather in the way they interact with D105 in the orthosteric binding site. Furthermore, our data demonstrate a key role of D105 in xanomeline wash-resistant binding and persistent activation of hM1 by wash-resistant xanomeline.

Original languageEnglish (US)
Pages (from-to)27-39
Number of pages13
JournalPharmacological Research
StatePublished - Jul 1 2015

Bibliographical note

Funding Information:
This work was supported by the Czech Academy of Sciences project [ AV0Z 50110509 ] and institutional support [ RVO:67985823 ], the Grant Agency of the Czech Republic grants [ 305/09/0681 ] and [ P304/12/G069 ] and Ministry of Education, Youth and Sports program [ OPVK CZ.1.07/2.3.00/30.0025 ].


  • Activation mechanism
  • Atypical agonists
  • Muscarinic acetylcholine receptors
  • Xanomeline

Fingerprint Dive into the research topics of 'Classical and atypical agonists activate M<sub>1</sub> muscarinic acetylcholine receptors through common mechanisms'. Together they form a unique fingerprint.

Cite this